Research Groups

Our mission is to identify and gain insights from the genetic and molecular pathways involved in atherosclerotic disease, and exploit these pathways to improve therapies with the aim of eradicating atherosclerotic diseases.

Our mission is to decode how lipids (fats) contribute to heart and blood vessel diseases as well as their related conditions, like diabetes, obesity and fatty liver. Using state-of the-art technologies, including AI-powered big data analytics, we aim to discover new strategies to predict, diagnose, prevent and treat these conditions.

The Cardiovascular Immunotherapy Unit is dedicated to advancing the understanding and treatment of cardiovascular diseases through innovative immunotherapeutic strategies.

Our mission is to investigate the pathophysiological aspects of cardiovascular diseases and the development of tissue engineering solutions for regeneration.

Our mission is to repurpose existing drugs for next-generation cardiovascular disease therapy.

Our mission is to detect the earliest signs of heart and blood vessel damage with a view to preventing serious complications later in life.

Our mission is to reduce death and disability associated with heart and lower limb arterial disease by reducing atherosclerotic plaque build-up.

We turn research into tangible and sustainable change in community, in healthcare, and in public policy to improve the quality of life of Aboriginal people.

Our focus is on understanding the differences between healthy heart enlargement and heart enlargement associated with disease.